Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington disease.

Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington disease. Neuropsychiatr Dis Treat. 2010 Oct 05; 6:657-65.

View in: PubMed

© 2021 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.